pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    OCX-909
    Glioblastoma Multiforme (GBM)$OCEA Ocean Biomedical, Inc.
  • Preclinical
    OKI-345
    Breast Cancer$OKUR OnKure Therapeutics, Inc.
  • Preclinical
    OM-301
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Oncolyze Inc
  • Phase 2
← prev
page 29 of 62
next →
Pain89
Neurology1
OMO-1
Solid Tumor
DeuterOncology NV
  • Phase 2
    ONC-841
    Colorectal Cancer OncoC4 Inc
  • Phase 1
    OP-3136
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$OLMA Olema Pharmaceuticals, Inc.
  • Preclinical
    OPB-171775
    Gastrointestinal Stromal Tumor (GIST)$BDRX Biodexa Pharmaceuticals Plc
  • Phase 1
    OPN-6602
    Refractory Multiple Myeloma Opna Bio SA
  • Preclinical
    OPTF-01
    Glioblastoma Multiforme (GBM) Optieum Biotechnologies Inc
  • Preclinical
    OQY-8811
    Multiple Myeloma (Kahler Disease) Oqory Inc
  • Preclinical
    OR-449
    Adrenocortical Carcinoma (Adrenal Cortex Cancer) Orphagen Pharmaceuticals Inc
  • Preclinical
    ORG-101
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla… Orgenesis Inc
  • Phase 3
    OSE-2101
    Tedopi
    Non-Small Cell Lung Cancer OSE Immunotherapeutics SA
  • Phase 1
    OTS-167
    Metastatic Breast Cancer OncoTherapy Science Inc
  • Phase 2
    OXI-4503
    Refractory Acute Myeloid Leukemia$OTLC Oncotelic Therapeutics, Inc.
  • Phase 3
    OncoVAX
    OncoVAX
    Colon Cancer Vaccinogen Inc
  • Preclinical
    Oncolipin-IT
    Colorectal Cancer XEME BioPharma Inc
  • Preclinical
    Oncoplex
    Glioblastoma Multiforme (GBM)$PYPD PolyPid Ltd.
  • Phase 1
    Oncoquest
    Oncoquest
    Chronic Lymphocytic Leukemia (CLL) XEME BioPharma Inc
  • Marketed
    Oncotice
    Tice BCG
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$MRK Merck & Co., Inc.
  • Marketed
    Opzelura
    Opzelura (ruxolitinib phosphate)
    Hidradenitis Suppurativa$INCY INCYTE CORP
  • Phase 2
    OriCAR-017
    Refractory Multiple Myeloma Oricell Therapeutics (Shanghai) Co Ltd
  • Preclinical
    Oxy-210
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Max Biopharma Inc
  • Phase 1
    P-01
    Pancreatic Cancer Hangzhou Neoantigen Therapeutics Co Ltd
  • Phase 1
    PAS-004
    Plexiform Neurofibroma$KTTA Pasithea Therapeutics Corp.
  • Phase 2
    PAX-1
    Bile Duct Cancer (Cholangiocarcinoma) Komipharm International Co Ltd
  • phase_0
    PBA-0111
    Alveolar Soft Part Sarcoma (ASPS) Pure Biologics SA
  • phase_0
    PBA-0405
    Alveolar Soft Part Sarcoma (ASPS) Pure Biologics SA
  • Phase 1
    PBCAR-19B
    Diffuse Large B-Cell Lymphoma$DTIL PRECISION BIOSCIENCES INC
  • Phase 2
    PBI-05204
    Metastatic Adenocarcinoma of The Pancreas Phoenix Biotechnology Inc